TaiwanJ Pharmaceuticals Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported net loss was TWD 9.54 million compared to net income of TWD 5.01 million a year ago. Basic loss per share from continuing operations was TWD 0.13 compared to basic earnings per share from continuing operations of TWD 0.07 a year ago. Diluted loss per share from continuing operations was TWD 0.13 compared to diluted earnings per share from continuing operations of TWD 0.07 a year ago. Basic loss per share was TWD 0.13 compared to basic earnings per share of TWD 0.07 a year ago. Diluted loss per share was TWD 0.13 compared to diluted earnings per share of TWD 0.07 a year ago.